JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chin, B. B.
Right arrow Articles by Kraitchman, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chin, B. B.
Right arrow Articles by Kraitchman, D. L.
Journal of Nuclear Medicine Vol. 43 No. 4 540-550
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Myocardial Contractile Reserve and Perfusion Defect Severity with Rest and Stress Dobutamine 99mTc-Sestamibi SPECT in Canine Stunning and Subendocardial Infarction

Bennett B. Chin, MD1, Giuseppe Esposito, MD2 and Dara L. Kraitchman, VMD, PhD1

1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland
2 Centro di Studio per la Medicina Nucleare, CNR, Naples, Italy

Myocardial contractile reserve and resting perfusion scintigraphy provide independent information to assess myocardial viability. The purpose of this study was to simultaneously evaluate both with 99mTc-sestamibi SPECT and low-dose dobutamine in canine stunning and subendocardial infarction (SEMI). Methods: Eighteen dogs were included in the study: 7 normal, 7 stunned, and 4 with SEMI. Closed-chest stunning and SEMI were produced by angioplasty balloon occlusion of the left anterior descending artery (20 and 90 min, respectively). Subsequent radiolabeled mircospheres confirmed reflow, and 99mTc-sestamibi was then administered at rest. Gated SPECT and MRI tagging were performed at rest and during low-dose dobutamine infusion (5 µg/kg/min). SPECT systolic wall thickening index (SWI) and MRI radial strain quantified myocardial contraction. Postmortem 2,3,5-triphenyltetrazolium chloride staining quantified SEMI. Results: Defect severity by SPECT in the anterior wall was mild and was not statistically different for the stunned versus SEMI groups (P = not significant). At rest, anterior wall SPECT SWI was significantly higher in the normal versus stunned groups (21.1 ± 3.1 vs. 10.1 ± 9.0; P = 0.0002) and the normal versus SEMI groups (21.1 ± 3.1 vs. 2.6 ± 6.0; P = 0.000002). With low-dose dobutamine, SWI increased significantly compared with rest for the stunned group (29.1 ± 10.4 vs. 10.1 ± 9.0; P = 0.000007) but did not increase significantly for the SEMI group (11.0 ± 11.3 vs. 2.6 ± 6.0; P = 0.09); SWI during low-dose dobutamine infusion for the stunned group was comparable to that for the normal group (29.1 ± 10.4 vs. 28.2 ± 7.0; P = 0.80). SWI also showed correlation with MRI radial strain (r = 0.42; P = 0.00015). Conclusion: Defect severity for stunned myocardium and SEMI was mild and was not significantly different. Contractile reserve was significantly different in stunned myocardium and SEMI. 99mTc-Sestamibi SPECT at rest and with low-dose dobutamine is a promising new technique to simultaneously assess myocardial perfusion and contractile reserve.

Key Words: myocardial infarction • myocardial stunning • 99mTc-sestamibi • contractile reserve • myocardial viability




This article has been cited by other articles:


Home page
JNMHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, S. Tange, T. Suzuki, and M. Kurabayashi
Dobutamine Stress 99mTc-Tetrofosmin Quantitative Gated SPECT Predicts Improvement of Cardiac Function After Carvedilol Treatment in Patients with Dilated Cardiomyopathy
J. Nucl. Med., November 1, 2004; 45(11): 1878 - 1884.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.